Find the investors funding Health IPO rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
ADARx bags $446.3M IPO as another siRNA startup readies for its debut - firstwordpharma.com
ADARx is a startup focused on siRNA technology. The company has successfully raised $446.3 million through an IPO, indicating significant investor confidence in its potential within the biotechnology sector.
ADARx bags $446.3M IPO as another siRNA startup readies for its debut firstwordpharma.com
| Nov 14, 2026 | Medallion | $30.0M | — | United States |
| Nov 13, 2026 | Avionova | $25K | Grant | Ireland |
| Nov 13, 2026 | PlatinumRx | $32.0M | — | — |
| Nov 13, 2026 | VectorY Therapeutics | $79 | — | Netherlands |
You just read who funded ADARx. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.